| 영문 | nuclear medicine | 한글 | 핵의학 |
|---|---|---|---|
| 설명 | 방사성을 띠는 핵물질을 이용하여 의학에 응용하는 학문. 대개 인체에 큰 해가 없는 방사선물질을 사용하며, 반감기가 짧아 사용후에도 큰 해가 없다. 이런 핵의학적 물질을 이용한 핵의학적 진단의 가장 큰 장점은 생체내에서 일어나는 그 기관의 실제적인 기능을 알아볼 수 있다는 데 있다. 흔히 접하는 X-선을 이용한 진단방법은 단지 그 순간만의 영상을 접하여 실제로 보이는 부위가 얼마나 기능을 수행하는지 알 수 없는 단점이 있으나, 핵의학에서는 실제적인 기능의 정도에 따라 영상이 나오게 되므로 기능판별에 아주 유리하다. 하지만, 정확한 판별력이 있는 영상을 얻기에는 부족하다. 또한 핵의학은 진단외의 치료에도 사용되는데, 예를 들어 갑상샘종양의 경우 여러 곳에 이미 전이가 되어 있을 경우 방사선핵종을 이용하여 다른 곳에 큰 부작용없이 치료가 가능하다. |
||
| 영문 | nuclear magnetic resonance(NMR) | 한글 | 핵자기공명 |
|---|---|---|---|
| 설명 | 다른 말로 MRI=Magnetic Resonance Imaging 자기공명영상이라고도 한다. 인체의 장기나, 병적인 모양, 종양의 위치, 림프절의 비대 등에 대한 진단을 내리기 위해 시행하는 방사선학적인 검사방법이다. 현재 많이 쓰이고 있는 컴퓨터단층촬영(CT=computerized tomography)과는 다른 방법으로 시행하며, 그 해상도가 컴퓨터단층촬영보다는 뛰어나 비록 고가이긴 하지만, 많이 쓰이고 있다. 또한 인체에 무해하고, 여러 가지 면(plane)에서 사람을 단층시켜 볼 수 있다. 단점은 심장박동기를 설치한 사람이나, 주위에 자장을 띠는 물체를 몸에 지니고 있는 중환자 등에서는 이용할 수 없고, 복부장기에 대한 진단에는 컴퓨터단층촬영보다 떨어지는 것으로 되어 있다. |
||
| HNF | hepatocyte nuclear factor |
|---|---|
| HNF1A | hepatocyte nuclear factor-1-alpha |
| HGF | hepatocyte growth factor; hyperglycemic-glucogenolytic factor |
| HGFL | hepatocyte growth factor-like [protein] |
| HSF | heat shock factor; hepatocyte stimulatory factor; histamine sensitizing factor; human serum esterase... |
| HNF3beta | Hepatocyte Nuclear Factor 3beta |
|---|---|
| HNF-4 | Hepatocyte Nuclear Factor 4 |
| HNF-1 alpha | Hepatocyte Nuclear Factor-1 alpha |
| HNF | Hepatocyte nuclear factor |
| HNF-1 | Hepatocyte nuclear factor 1 |
| hepatocyte | <pathology> Epithelial cell of liver. Often considered the paradigm for an unspecialised animal cell. Blood is directly exposed to hepatocytes through fenestrated endothelium and hepatocytes have receptors for sub terminal N acetyl galactosamine residues on asialo glycoproteins of plasma. (18 Nov 1997) |
|---|---|
| hepatocyte growth factor | <growth factor> Polypeptide mitogen originally shown to cause cell division in hepatocytes. In the liver, the main sources of hepatocyte growth factor are nonparenchymal cells. It is now clear that hepatocyte growth factor is a mitogen for a number of cell types and it is found in many cells outside the liver, including platelets. Hepatocyte growth factor is synthesised as a single chain precursor that is proteolytically cleaved to give a heavy chain (70 kD) and a light chain (30 kD) linked by a single disulphide bond. It contains multiple copies of the kringle domain. However, both the single chain precursor and the two chain forms of hepatocyte growth factor are biologically active and hepatocyte growth factor is generally isolated as a mixture of the two forms. Hepatocyte growth factor also alters cell motility and is now known to be identical to scatter factor. Acronym: HGF (18 Nov 1997) |
| age factors | Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from aging, a physiological process, and time factors which refers only to the passage of time. (12 Dec 1998) |
| bacteriocin factors | Bacterial plasmid's responsible for the elaboration of bacteriocins. Synonym: bacteriocin factors, bacteriocinogens. (05 Mar 2000) |
| B-cell differentiation/growth factors | Various substances, usually obtained from the supernatant of T-cell cultures, such as interleukin 4, 5, and 6. These substances are necessary for B-cell growth, maturation, and differentiation into plasma cells or B memory cells. (05 Mar 2000) |
| biological factors | Compounds made by living organisms. They have biological or physiological activities. (12 Dec 1998) |
| biotic factors | Environmental factor's or influences resulting from the activities of living organisms, as contrasted to those resulting from climatic, geological, or other factor's. (05 Mar 2000) |
| blood coagulation factors | Endogenous substances, usually proteins, that participate in the blood coagulation process. (12 Dec 1998) |
| macrophage migration-inhibitory factors | Proteins released by sensitised lymphocytes and possibly other cells that inhibit the migration of macrophages away from the release site. The structure and chemical properties may vary with the species and type of releasing cell. (12 Dec 1998) |
| recognition factors | Factors which effect "recognition" of target antigens by polymorphonuclear leukocytes; apparently the Fc portion of antibody molecules and the activated third component of complement (C3), for both of which phagocytes have receptor sites. (05 Mar 2000) |
| glaucoma, risk factors | If you belong to a high-risk group for glaucoma, have your eyes examined through dilated pupils every 2 years by an eye care professional. High-risk groups include everyone with a family history of glaucoma, everyone over the age of 60 and any Black over the age of 40. (Among Blacks, studies show that glaucoma is: 5 times more likely to occur in Blacks than in Whites and about 4 times more likely to cause blindness in Blacks than in Whites). (12 Dec 1998) |
| releasing factors | Hormones produced by the hypothalamus whichstimulate the release of other hormones in the pituitary gland. (09 Oct 1997) |
| resistance factors | Plasmid's carrying genes responsible for antibiotic (or antibacterial drug) resistance among bacteria (notably Enterobacteriaceae); they may be conjugative or nonconjugative plasmid's, the former possessing transfer genes (resistance transfer factor) lacking in the latter. Synonym: R factors, R plasmids, resistance factors, resistance-transferring episomes. (05 Mar 2000) |
| peptide elongation factors | Protein factors uniquely required during the elongation phase of protein synthesis. (12 Dec 1998) |
| peptide initiation factors | Protein factors uniquely required during the initiation phase of protein synthesis. (12 Dec 1998) |
Synonyms :
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|